Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 4 | Respiratory Research

Fig. 4

From: Targeting of nicotinamide phosphoribosyltransferase enzymatic activity ameliorates lung damage induced by ischemia/reperfusion in rats

Fig. 4

Effect of FK866 on CINC-1, TNF-α, and IL-6 levels, and total cell counts in bronchoalveolar lavage fluid (BALF). CINC-1 (a), TNF-α (b) and IL-6 (c) levels, and total cell counts (d) in the BALF significantly increased in the ischemia-reperfusion (IR) group. Treatment with FK866 significantly attenuated these increases in the BALF. Data are expressed as mean ± SD (n = 6 per group). ***p < 0.001, compared with the control group; +++ p < 0.001, compared with the IR group

Back to article page